En videnskabelig podcast for sundhedsfagligt personale med interesse inden for hæmatologi. <br /><br />HæmatoLOGIK produceres af hearHEAR for AbbVie.
HæmatoLOGIK
Claim This Podcastby dansk podcast
5.0(8 reviews)
70 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇩🇰
Podcast Overview
En videnskabelig podcast for sundhedsfagligt personale med interesse inden for hæmatologi. <br /><br />HæmatoLOGIK produceres af hearHEAR for AbbVie.
Language
🇩🇰
Publishing Since
5/25/2022
1 verified contact email on file for HæmatoLOGIK
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 15, 2026
[ CLL ] Førstelinje behandling af CLL i 2026 /m. gæst Christian Poulsen
<i>[HæmatoLOGIK er henvendt til sundhedsfagligt personale]</i><br /><br />I denne episode løfter Ulrik Overgaard og Troels Hammer blikket fra CLL17-studiet, zoomer ud og stiller spørgsmålet: Hvordan skal CLL behandles i første linje i Danmark anno 2026? Sammen med CLL-nørd, overlæge og leder for KFE og fase 1, Christian Poulsen diskuterer de, hvad man egentlig skal tilbyde patienten, når sygdommen bliver behandlingskrævende.<br /><br />Med den fiktive patient “Preben” som rød tråd kommer episoden omkring behandlingsindikation, TP53/del(17p), IGHV-status, komorbiditet, patientpræferencer, logistik, adherence og bivirkninger. Undervejs diskuterer de tre hæmatologer også kemoimmunterapiens plads i 2026, MRD-styret behandling og fremtidens CLL-landskab. <br /><br />Links til publikationer og studier:<br /><ul><li>TP53-aberrated CLL: is BTK inhibitor monotherapy enough? (kommentar om BTK-hæmmer monoterapi ved TP53-aberreret CLL):<br /><a href="https://ashpublications.org/bloodadvances/article/10/3/707/566313/TP53-aberrated-CLL-is-BTK-inhibitor-monotherapy" target="_blank" rel="noreferrer noopener">https://ashpublications.org/bloodadvances/article/10/3/707/566313/TP53-aberrated-CLL-is-BTK-inhibitor-monotherapy</a><br /><br /></li><li>Is CLL curable? (editorial om hvorvidt CLL kan være kurabel):<br /><a href="https://onlinelibrary.wiley.com/doi/10.1002/hem3.70308" target="_blank" rel="noreferrer noopener">https://onlinelibrary.wiley.com/doi/10.1002/hem3.70308</a><br /><br /></li><li>First-line treatment for CLL in the era of targeted therapy (artikel om førstelinjebehandling af CLL i æraen med targeteret behandling):<br /><a href="https://www.nature.com/articles/s41408-025-01434-2" target="_blank" rel="noreferrer noopener">https://www.nature.com/articles/s41408-025-01434-2</a><br /><br /></li><li>CLL17-studiet - Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia:<br /><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2515458" target="_blank" rel="noreferrer noopener">https://www.nejm.org/doi/full/10.1056/NEJMoa2515458</a><br /><br /></li><li>ClinicalTrials.gov-registrering af CLL17-studiet:<br /><a href="https://clinicaltrials.gov/study/NCT04608318" target="_blank" rel="noreferrer noopener">https://clinicaltrials.gov/study/NCT04608318</a></li></ul><br />Værter:<br /><ul><li>Ulrik Overgaard, overlæge</li><li>Troels Hammer, overlæge</li></ul>Gæst:<br /><ul><li>Christian Poulsen, overlæge, leder for KFE og fase 1 på Sjællands Universitetshospital og lektor på Københavns Universitet.. </li></ul><br /><br />Arbejdsgruppen bag HæmatoLOGIK er Ulrik Overgaard, Troels Hammer, Emilie Clausen og Anders Guldberg. Manus af Anders Guldberg. Original musik af Kasper Møller. Redigeret og mixet af hearHEAR || <a href="https://www.dropbox.com/scl/fo/tnjr00ia76ssd21raujes/ALJJN9PE6ejRc2BxlQKANSY?rlkey=alzereqxwzew5199hs1iu44ye&st=14sqfb39&dl=0" target="_blank" rel="noreferrer noopener">Pligttekst</a> || DK-VNCCLL-260016<br /><br />Podcasten produceres for AbbVie af podcastbureuaet hearHEAR.<br /><br />Alle episoder kan lyttes på Spotify, Apple podcast - eller din foretrukne podcast-app. Hvis du kan lide podcasten, så anbefal HæmatoLOGIK til en kollega!
June 8, 2026
[ CLL ] Fixed-Duration versus Continuous Treatment for CLL /m. gæst Christian Poulsen
<i>[HæmatoLOGIK er henvendt til sundhedsfagligt personale]</i><br /><br />Dine podcastværter Ulrik Overgaard og Troels Hammer skyder sæson 13 af HæmatoLOGIK i gang med to stærke episoder om CLL. I denne første episode gennemgår de CLL17-studiet: “Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia”. <br /><br />Det gør de sammen med dagens gæst, Christian Poulsen, der er overlæge, leder af KFE og fase 1 på Sjællands Universitetshospital og lektor ved Københavns Universitet. <br /><br />Episoden er en klassisk Journal Club, hvor overlægerne diskuterer det centrale spørgsmål om, hvorvidt tidsbegrænset behandling med venetoclax-obinutuzumab eller venetoclax-ibrutinib kan stå mål med kontinuerlig ibrutinib-behandling hos patienter med tidligere ubehandlet CLL. Selvfølgelig med nørdede afstikkere undervejs.<br /><br /><br />Links til studie: <a href="https://pubmed.ncbi.nlm.nih.gov/41358601/" target="_blank" rel="noreferrer noopener">https://pubmed.ncbi.nlm.nih.gov/41358601/</a> <br /><br />Værter:<br /><ul><li>Ulrik Overgaard, overlæge</li><li>Troels Hammer, overlæge</li></ul>Gæst:<br /><ul><li>Christian Poulsen, overlæge, leder for KFE og fase 1 på Sjællands Universitetshospital og lektor på Københavns Universitet.. </li></ul><br /><br />Arbejdsgruppen bag HæmatoLOGIK er Ulrik Overgaard, Troels Hammer, Emilie Clausen og Anders Guldberg. Manus af Anders Guldberg. Original musik af Kasper Møller. Redigeret og mixet af hearHEAR || <a href="https://www.dropbox.com/scl/fo/tnjr00ia76ssd21raujes/ALJJN9PE6ejRc2BxlQKANSY?rlkey=alzereqxwzew5199hs1iu44ye&st=14sqfb39&dl=0" target="_blank" rel="noreferrer noopener">Pligttekst</a> || DK-VNCCLL-260015 <br /><br />Podcasten produceres for AbbVie af podcastbureuaet hearHEAR.<br /><br />Alle episoder kan lyttes på Spotify, Apple podcast - eller din foretrukne podcast-app. Hvis du kan lide podcasten, så anbefal HæmatoLOGIK til en kollega!
May 28, 2026
EHA2026: Nordic Hema Night
Tilmeld dig Nordic Hema Night: <a href="https://www.abbviemeetings.com/event/1b93cdff-7672-429b-a1d5-9cc502a21e96/register" target="_blank" rel="noreferrer noopener">https://www.abbviemeetings.com/event/1b93cdff-7672-429b-a1d5-9cc502a21e96/register</a><br /><br />Medvirkende: <br />Ulrik Overgaard, hæmatologisk overlæge, Rigshospitalet <br />Emilie Clausen, cand.pharm., Abbvie<br /><br />Hæmatologik udgives af Abbvie || DK-VNCCLL-260017 27maj2026
70 total episodes available
Recent guests on HæmatoLOGIK
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Anders Pommer Vallentin
Guest
Stine Clemmensen
Guest
Waleed Ghanima
Guest
Sigrún Thorsteinsdóttir
Guest
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for HæmatoLOGIK
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is HæmatoLOGIK?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.